NCT04617015View on ClinicalTrials.gov

Defining and Treating Depression-related Asthma

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 9, 2016

Primary Completion Date

March 11, 2019

Study Completion Date

March 11, 2019

Conditions
AsthmaDepressionChildhood Asthma
Interventions
DRUG

Ipratropium Bromide

All subjects receive inhaled ipratropium once with measurement of spirometry before and after. Bronchodilator response of subjects with depression is compare to that of subjects without depression.

Trial Locations (1)

14222

Women and Children's Hospital of Buffalo, Buffalo

All Listed Sponsors
collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

State University of New York at Buffalo

OTHER

NCT04617015 - Defining and Treating Depression-related Asthma | Biotech Hunter | Biotech Hunter